Navigation Links
M2S Announces New Addition to Electronic Image Management Offering for Clinical Trials
Date:3/10/2009

he best customized solution.

About M2S, Inc.
M2S is a full-service imaging CRO, providing high-quality, timely and cost-effective image data management services for clinical trial sponsors in the biopharmaceutical and medical device industries as well as patient registry databases. For the past 10 years, M2S has managed, under protocol, millions of images from around the globe in all major therapeutic areas and in all DICOM modalities. For more information, visit www.m2s.com.

About AG Mednet, Inc.
AG Mednet, Inc. is a global diagnostic imaging network. Pharmaceutical, biotech and medical device companies, core labs and clinical research organizations utilizing imaging technology as part of their trial protocol rely on AG Mednet's automated system to enable the secure electronic transfer of cases from hundreds of locations, enhancing site compliance while providing detailed reporting necessary to meet the most stringent regulatory requirements. Additional information about AG Mednet is available at www.agmednet.com.

# # #

Read the full story at http://www.prweb.com/releases/clinical/tirals/prweb2217894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Natural Alternatives International, Inc. Announces Carnosyn(R) Beta-Alanine Licensing Agreement
2. ULURU Inc. Announces Senior Management Change
3. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
4. National Western Life Announces 2008 Fourth Quarter and 2008 Earnings
5. Celebrity Chef Cat Cora Announces First Pregnancy
6. National Patient Advocate Foundation Announces 2009 Elections of Health Policy Leaders to Executive Board of Directors
7. CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa
8. Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information
9. Victory Pharma Announces $45 Million Equity Financing
10. Email Fax Provider, EasyLink Services, Announces Prominent Bio-Pharma Signing
11. Pharmos Corporation Announces Receipt of Nasdaq Delisting Determination
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
M2S Announces New Addition to Electronic Image Management Offering for Clinical Trials
(Date:7/29/2015)... CA (PRWEB) , ... July 29, 2015 , ... ... Honduras with the Hackett Hemwall Foundation in March, Steven W. Meier M.D., a ... bono prolotherapy treatments to qualifying patients with demonstrated financial need. , “We are ...
(Date:7/29/2015)... ... July 29, 2015 , ... It is unique for a ... a tremendous model of care. One that is very hands on and resident oriented, ... of Monarch Landing. “She’s bringing great passion and energy, as well as a strong ...
(Date:7/29/2015)... Madison, Wis. (PRWEB) , ... July 29, 2015 ... ... enrolled its first two patients in a Clinical Performance Study for the Invisiport ... includes 4.4 and 6 French catheter options, offers a less invasive, patient-friendly alternative ...
(Date:7/29/2015)... ... July 29, 2015 , ... TransFlip is an all ... drag & drop presets for FCPX, these transitions are easy to apply and modify ... to each transition. With over 60 preset styles, kinetic flipping panel animations are just ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... a decision from the Judicial Panel on Multidistrict Litigation (JPML), according to court ... defects research at their website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, ...
Breaking Medicine News(10 mins):Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4
... Duke university Medical Center have established that an ... by a complex interplay between genetic and environmental ... role in determining the psychological and biological response ... of four such studies that examined the genetic-environment ...
... James Levine, an endocrinologist at the Rochester, Minnesota, medical college, ... days on treadmills or indoor tracks, walking as they talk ... at the Mayo clinic said that a walking worker can ... results of the research are published in the journal Science ...
... have a VAT of 17.5% on them. This is expected ... ensuing budget.,Gordon Brown is due to present the budget later ... Superdrug which said that it was confident of the action. ... move followed a successful 10-month campaign. ,Superdrug managing ...
... All the hullabaloo about the goodness of Vitamin E is ... it now.,Researchers at Ohio State University who studied how two ... cells// have proposed the hypothesis. ,In the past couple ... been extensively studied. Most of it in the favour while ...
... in Orissa ostracized a HIV positive woman and her two ... classroom in their school//. ,Sanjukta, 34, lost her ... elder daughter have been infected, the younger daughter is healthy, ... ,Soon after her husband Pradeep Nayak's death in January, ...
... : Women, If you have been physically or mentally active ... your body is better equipped to churn out antibodies// ... before a flu shot! This has been suggested by a ... study is detailed in the March issue of the journal ...
Cached Medicine News:Health News:Genes And Environmental Factors Determine Stress Response 2Health News:Vitamin E: good, bad or ugly??? 2
(Date:7/29/2015)... CHENNAI, India , July 29, 2015 TAKE ... its foray into the big data market for the Life ... new US-based subsidiary, with an initial investment of 3 ... billion healthcare and life sciences market (according to projections by ... integration and advanced analytics. ...
(Date:7/29/2015)... -- Commenting on GSK,s Q2 performance, the ... Dingemans reveals sales rose during the period and ... expectations. Ahead of a November R&D update day he ... The interview and transcript are available now on ... and webcasts with senior company executives. If you would ...
(Date:7/29/2015)... , July 29, 2015 Cogentix Medical, Inc. (NASDAQ: ... the urology market, will release financial results for the first ... after the market close on Monday, August 10, 2015. ... webcast to discuss these results on Monday, August 10, 2015 ... Rob Kill , President and Chief Executive Officer, and ...
Breaking Medicine Technology:TAKE Solutions Creates a New Subsidiary for Life Sciences Big Data in the US 2TAKE Solutions Creates a New Subsidiary for Life Sciences Big Data in the US 3Cogentix Medical to Announce First Quarter Fiscal 2016 Results on August 10, 2015 2
... , ATLANTA, Nov. 23 CryoLife, Inc. ... and cardiovascular tissue processing company, announced today that it is ... Health Care Conference at The New York Palace Hotel on ... executive officer of CryoLife, Inc., will provide a corporate overview ...
... , FORT WORTH, Texas, Nov. 23 Wound ... specialty medical products, announced that it has filed it Q3 2009 financial ... developments during the 2009 calendar year. , Q3 2009 sales increased ... Shareholder equity as of the Q3 2009 increased to $3,327,892 vs. ...
Cached Medicine Technology:CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 6
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: